| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-04 | NCT07744724 Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL | Phase 2 | Not Yet Recruiting |
| 2026-08-04 | NCT07744737 Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL | Phase 2 | Not Yet Recruiting |
| 2026-08-04 | NCT07744750 Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06403111 | FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced… | Non-small Cell Lung Cancer | Recruiting |
| NCT06405113 | FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer | Gastric Cancer | Recruiting |
| NCT07744724 | Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL | DLBCL - Diffuse Large B Cell Lymphoma | Not Yet Recruiting |
| NCT07744737 | Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL | DLBCL - Diffuse Large B Cell Lymphoma | Not Yet Recruiting |
| NCT07744750 | Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Not Yet Recruiting |
| Phase 1 | |||
| NCT06404281 | γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors | Advanced Solid Tumor | Recruiting |
| NCT06978738 | UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune… | Systemic Lupus Erythematosus | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06337474 | An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune… | Thrombocytopenia Alloimmune | Recruiting |
| Not specified | |||
| NCT06964867 | Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous… | Vitreous Floaters | Recruiting |